Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Depreciation & Amortization (CF): 2012-2024

Historic Depreciation & Amortization (CF) for Tvardi Therapeutics (TVRD) over the last 13 years, with Dec 2024 value amounting to $192,000.

  • Tvardi Therapeutics' Depreciation & Amortization (CF) rose 5.04% to $125,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $495,000, marking a year-over-year decrease of 66.21%. This contributed to the annual value of $192,000 for FY2024, which is 25.87% down from last year.
  • Latest data reveals that Tvardi Therapeutics reported Depreciation & Amortization (CF) of $192,000 as of FY2024, which was down 25.87% from $259,000 recorded in FY2023.
  • Tvardi Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $259,000 for FY2023, and its period low was $192,000 during FY2024.
  • Over the past 3 years, Tvardi Therapeutics' median Depreciation & Amortization (CF) value was $248,000 (recorded in 2022), while the average stood at $233,000.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first climbed by 18.66% in 2021, then dropped by 25.87% in 2024.
  • Yearly analysis of 5 years shows Tvardi Therapeutics' Depreciation & Amortization (CF) stood at $209,000 in 2020, then grew by 18.66% to $248,000 in 2021, then remained steady at $248,000 in 2022, then grew by 4.44% to $259,000 in 2023, then declined by 25.87% to $192,000 in 2024.